Understanding SEC13: A Protein Potential Drug Target Or Biomarker

Target Name: SEC13

NCBI ID: G6396

SEC13

Understanding SEC13: A Protein Potential Drug Target Or Biomarker

SEC13 is a protein that is found in the nucleus of all eukaryotic cells. It is a key component of the nuclear pore complex, which is the structure that allows RNA to leave the nucleus and enter the cytoplasm. SEC13 is also involved in the transport of proteins into the nucleus, and is thought to play a role in the regulation of gene expression.

Recent studies have suggested that SEC13 may be a drug target or biomarker for a variety of diseases. For example, some researchers have found that SEC13 is highly expressed in various types of cancer, and that inhibiting its activity may be a promising approach for treating these diseases. Additionally, studies have also suggested that SEC13 may be involved in a variety of neurological and psychiatric disorders, and that targeting its activity may be a potential new treatment for these conditions.

Despite these promising findings, much more research is needed to fully understand the role of SEC13 in the cell. In particular, researchers are needed to determine exactly how the activity of SEC13 is regulated and how it interacts with other proteins in the nucleus. Additionally, researchers would be interested in studying the effects of inhibiting SEC13 activity on cellular processes and behaviors, such as cell division, apoptosis, and transcriptional regulation.

Overall, SEC13 is a protein that has great potential as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in the cell and its potential as a therapeutic target.

Protein Name: SEC13 Homolog, Nuclear Pore And COPII Coat Complex Component

Functions: Functions as a component of the nuclear pore complex (NPC) and the COPII coat. At the endoplasmic reticulum, SEC13 is involved in the biogenesis of COPII-coated vesicles (PubMed:8972206). Required for the exit of adipsin (CFD/ADN), an adipocyte-secreted protein from the endoplasmic reticulum (By similarity)

The "SEC13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEC13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets